focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RBSG successfully priced $3.15bn Additional Tier

6 Aug 2015 07:00

RNS Number : 2755V
Royal Bank of Scotland Group PLC
06 August 2015
 



THE ROYAL BANK OF SCOTLAND GROUP PLC

The Royal Bank of Scotland Group plc successfully priced $3.15 billion Additional Tier 1 Capital Notes

06 August 2015

The Royal Bank of Scotland Group plc ("RBSG") completed the pricing of its:

§ USD 2,000,000,000 7.500% Perpetual Subordinated Contingent Convertible Additional Tier 1 Capital Notes callable 10 August 2020; and

§ USD 1,150,000,000 8.000% Perpetual Subordinated Contingent Convertible Additional Tier 1 Capital Notes callable 10 August 2025

(together, the "Notes").

 

Ross McEwan, RBSG CEO said:

"This is another important step in the road towards becoming a much stronger, safer bank for our customers and shareholders. Improving our capital resilience has been an integral part of our plan and we are well on track to achieve this."

 

RBSG's leverage ratio at 30 June 2015 on a pro forma basis, assuming the divestment of Citizens and including the benefit of this issuance, would have been 5.3%

 

The net proceeds of approximately USD 3,118,500,000 will be used for general corporate purposes.

 

The offering is scheduled to close on 10 August 2015 subject to the satisfaction of customary conditions. Application has been made to The Irish Stock Exchange plc for the Notes to be admitted to the Official List and to trading on the Global Exchange Market, which is the exchange regulated market of The Irish Stock Exchange plc.

 

 

For further information:

 

RBS Investor Relations

Matthew Richardson

Head of Debt Investor Relations

Tel: +44 (0) 20 7678 1800

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements that include the words "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBSG's future economic results, business plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBSG's actual results are discussed in RBSG's UK Annual Report and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBSG's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBSG does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

The securities referred to in this press release are not intended to be sold and should not be sold to retail clients in the European Economic Area, as defined in the rules set out in the Temporary Marketing Restriction (Contingent Convertible Securities) Instrument 2014 or the Product Intervention (Contingent Convertible Instruments and Mutual Society Shares) Instrument 2015 (together, the "MR Rules"), as amended or replaced from time to time, other than in circumstances that do not and will not give rise to a contravention of those rules by any person.

 

Notice to U.S. persons: The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in the registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, the issuer or any underwriter participating in the offering will arrange to send you the prospectus if you request it by calling RBS Securities Inc. toll-free at 1-866-884-2071, calling Credit Suisse Securities (USA) LLC toll-free at 1-800-221-1037, contacting Merrill Lynch, Pierce, Fenner & Smith Incorporated at 222 Broadway, New York, NY 10038, Attn: Prospectus Department (email: dg.prospectus_requests@baml.com) and calling Morgan Stanley & Co. LLC toll-free at 1-866-718-1649.

 

Notice to U.K. persons: This communication has not been approved by an authorized person for the purposes of section 21 of the Financial Services and Markets Act 2000 (as amended) ("FSMA"). Accordingly, this communication is only for distribution to and directed at: (i) in the United Kingdom, persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") and high net worth entities falling within Article 49(2)(a) to (d) of the Order; (ii) persons who are outside the United Kingdom; and (iii) any other person to whom it can otherwise be lawfully distributed (all such persons together being referred to as "Relevant Persons"). Any investment or investment activity to which this communication relates is available only to and will be engaged in only with Relevant Persons. Persons who are not Relevant Persons should not take any action based upon this communication and should not rely on it. 

 

Other Jurisdictions Outside the United States: No action may be taken in any jurisdiction other than the United States that would permit a public offering of the securities referred to in this press release or the possession, circulation or distribution of this document or the prospectus in any jurisdiction where action for that purpose is required. Accordingly, such securities may not be offered or sold, directly or indirectly, and neither this document, the prospectus nor any other offering material or advertisements in connection with such securities may be distributed or published in or from any country or jurisdiction, except under circumstances that will result in compliance with any applicable rules and regulations of any such country or jurisdiction.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGUGDILUGBGUL
Date   Source Headline
10th Jul 201710:05 amRNSHolding(s) in Company
6th Jul 201711:03 amRNSTotal Voting Rights
30th Jun 20175:38 pmRNSAllotment and Issue of New Ordinary Shares
30th Jun 20171:24 pmRNSTotal Voting Rights
16th Jun 20178:19 amRNSCapital reorganisation - notice of completion
15th Jun 20176:21 pmRNSRBS welcomes credit rating upgrade by Moody's
8th Jun 20172:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20172:12 pmRNSBlock Listing Cancellation
1st Jun 201710:15 amRNSDirector Declaration
31st May 20175:36 pmRNSDividend Declaration
31st May 20172:55 pmRNSTotal Voting Rights
30th May 20178:00 amRNSDeutsche Bank Global Financial Services Conference
16th May 20175:08 pmRNSCapital Reorganisation - notice of petition
12th May 20172:00 pmRNSDirector/PDMR Shareholding
11th May 20176:03 pmRNSResult of AGM
11th May 20171:55 pmRNSAGM Statement
11th May 20171:45 pmRNSDirectorate Change
11th May 201710:30 amRNSRBSG priced $3.0 billion Senior Notes
9th May 20175:40 pmRNSPublication of Supplementary Prospectus
28th Apr 20175:55 pmRNSRBS Holdings N.V. and Royal Bank of Scotland N.V.
28th Apr 20175:25 pmRNSPublication of Supplementary Prospectus
28th Apr 201710:50 amRNSTotal Voting Rights
28th Apr 20177:00 amRNS1st Quarter Results
25th Apr 20175:36 pmRNSDividend Declaration
24th Apr 20175:30 pmRNSAllotment and Issue of New Ordinary Shares
19th Apr 20174:48 pmRNSBlock listing Interim Review
6th Apr 20172:00 pmRNSNotice of AGM
31st Mar 20172:37 pmRNSNotices of Redemption
31st Mar 20172:10 pmRNSTotal Voting Rights
27th Mar 201711:05 amRNSFiling of Annual Report on Form 20F with SEC
21st Mar 20179:30 amRNSMorgan Stanley European Financials Conference
8th Mar 20172:30 pmRNSDirector/PDMR Shareholding
6th Mar 20174:59 pmRNSPublication of Final Terms
28th Feb 20172:40 pmRNSTotal Voting Rights
27th Feb 20174:45 pmRNSDirector/PDMR Shareholding
27th Feb 20173:00 pmRNSAdditional Listing
24th Feb 20175:22 pmRNSPublication of Suppl.Prospcts
24th Feb 20177:06 amRNSDirectorate Change
24th Feb 20177:01 amRNSAnnual Financial Report
24th Feb 20177:00 amRNSFinal Results
23rd Feb 201712:25 pmRNSDividend Declaration
20th Feb 20177:00 amRNSUpdate on RBS's remaining State Aid obligation
31st Jan 20173:37 pmRNSTotal Voting Rights
26th Jan 20177:00 amRNSAdditional provision for US RMBS investigations
3rd Jan 20173:00 pmRNSRing-fencing Legal Entity Transfers
30th Dec 201611:43 amRNSTotal Voting Rights
16th Dec 20166:04 pmRNSPublication of a Prospectus
9th Dec 20168:30 amRNSRBS Investor Seminar
5th Dec 20167:00 amRNSMajority settlement of 2008 shareholder Litigation
30th Nov 20162:36 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.